SCHEMBL803269

SCHEMBL803269

O=C(O)c1ccc2c(c1)[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.58
PDE4A P27815 2/20 0.47
PDE4B Q07343 2/20 0.47
PDE4C Q08493 2/20 0.47
PDE4D Q08499 2/20 0.47
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
KCNA5 P22460 2/20 0.44
ALDH1A1 P00352 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TBXA2R P21731 4/20 0.43
CHEK2 O96017 1/20 0.43
METAP2 P50579 3/20 0.43
TDP1 Q9NUW8 1/20 0.42
RORC P51449 1/20 0.42
RB1 P06400 1/20 0.41
PSEN1 P49768 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL785324 1.00 CYP1A2 (0.58) CYP1A2PDE4APDE4BPDE4CPDE4D
SCHEMBL803299 0.89 CYP1A2 (0.65) CYP1A2PDE4APDE4BPDE4CPDE4D
SCHEMBL785532 0.89 CYP1A2 (0.65) CYP1A2PDE4APDE4BPDE4CPDE4D
SCHEMBL803223 0.87 PDE4A (0.52) CYP1A2PDE4APDE4BPDE4CPDE4D
SCHEMBL2817671 0.81 CYP1A2 (0.50) CYP1A2PDE4APDE4BPDE4CPDE4D
SCHEMBL785332 0.81 KMT2A (0.49) PDE4APDE4BPDE4CPDE4DMEN1
SCHEMBL785333 0.81 KMT2A (0.49) PDE4APDE4BPDE4CPDE4DMEN1
SCHEMBL10405757 0.79 CYP1A2 (0.65) CYP1A2PDE4APDE4BPDE4CPDE4D
SCHEMBL803521 0.78 CYP1A2 (0.54) CYP1A2PDE4APDE4BPDE4CPDE4D
SCHEMBL2818105 0.78 CYP1A2 (0.48) CYP1A2PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 CYP1A2 1988/4885PDE4A 944/4885PDE4B 939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.